Literature DB >> 17241660

Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

Neil E Kay1, Tait D Shanafelt, Ann K Strege, Yean K Lee, Nancy D Bone, Azra Raza.   

Abstract

A novel bone biopsy technique was used to generate a robust stromal cell system to study how stroma modulates CLL B-cell apoptosis and how the leukemic cell-stromal interaction influences secretion of vascular factors. Marrow stromal elements (MSE) rescued CLL B-cells from both spontaneous and drug induced apoptosis, partly due to soluble factors. When CLL B-cells were added to the MSE cultures, a dramatic increase in the secretion of basic fibroblast growth factor and decrease in the secretion of thrombospondin was observed. These results indicate the interaction between CLL B-cells and marrow stromal elements regulates angiogenic switching and may be linked to disease progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17241660      PMCID: PMC2505044          DOI: 10.1016/j.leukres.2006.11.024

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  38 in total

1.  Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine.

Authors:  Maria Teresa de la Fuente; Benito Casanova; José V Moyano; Mercedes Garcia-Gila; Laura Sanz; José Garcia-Marco; Augusto Silva; Angeles Garcia-Pardo
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

Review 2.  Chronic B cell malignancies and bone marrow microenvironment.

Authors:  Paolo Ghia; Luisa Granziero; Marco Chilosi; Federico Caligaris-Cappio
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

Review 3.  Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells.

Authors:  Jan A Burger; Thomas J Kipps
Journal:  Leuk Lymphoma       Date:  2002-03

4.  Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes.

Authors:  S Alvi; A Shaher; V Shetty; B Henderson; B Dangerfield; F Zorat; L Joshi; S Anthwal; L Lisak; L Little; S Gezer; S Mundle; P L Reddy; K Allampallam; X Huang; N Galili; R Z Borok; A Raza
Journal:  Leuk Res       Date:  2001-11       Impact factor: 3.156

5.  B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.

Authors:  N E Kay; N D Bone; R C Tschumper; K H Howell; S M Geyer; G W Dewald; C A Hanson; D F Jelinek
Journal:  Leukemia       Date:  2002-05       Impact factor: 11.528

Review 6.  Biology of chronic lymphocytic leukemia.

Authors:  F Caligaris-Cappio
Journal:  Rev Clin Exp Hematol       Date:  2000-03

Review 7.  Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies.

Authors:  J L Gabrilove
Journal:  Oncologist       Date:  2001

8.  Hydroxychloroquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase-3 and modulation of Bcl-2/bax/ratio.

Authors:  Laurence Lagneaux; Alain Delforge; Marielle Dejeneffe; Martine Massy; Michel Bernier; Dominique Bron
Journal:  Leuk Lymphoma       Date:  2002-05

Review 9.  Role of angiogenesis in tumor growth and metastasis.

Authors:  Judah Folkman
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

10.  Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia.

Authors:  S Molica; G Vitelli; D Levato; A Ricciotti; G Digiesi
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more
  39 in total

1.  Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.

Authors:  Iris Gehrke; Rajesh Kumar Gandhirajan; Simon Jonas Poll-Wolbeck; Michael Hallek; Karl-Anton Kreuzer
Journal:  Mol Med       Date:  2011-04-14       Impact factor: 6.354

2.  Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.

Authors:  Zachary A Hing; Rose Mantel; Kyle A Beckwith; Daphne Guinn; Erich Williams; Lisa L Smith; Katie Williams; Amy J Johnson; Amy M Lehman; John C Byrd; Jennifer A Woyach; Rosa Lapalombella
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 3.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

4.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

5.  RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.

Authors:  Jingjing Xu; Peng Zhou; Wenjuan Wang; Aining Sun; Feng Guo
Journal:  J Mol Med (Berl)       Date:  2013-09-17       Impact factor: 4.599

6.  Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.

Authors:  Jessie-F Fecteau; Davorka Messmer; Suping Zhang; Bing Cui; Liguang Chen; Thomas J Kipps
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

7.  Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.

Authors:  Asish K Ghosh; Charla R Secreto; Traci R Knox; Wei Ding; Debabrata Mukhopadhyay; Neil E Kay
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

8.  Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

Authors:  Tait D Shanafelt; John C Byrd; Betsy LaPLant; Clive S Zent; Tim Call; Charla Secreto; Michael R Grever; Thomas S Lin; Neil E Kay
Journal:  Br J Haematol       Date:  2009-07-10       Impact factor: 6.998

9.  Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

Authors:  Charalampos Pontikoglou; Maria-Christina Kastrinaki; Mirjam Klaus; Christina Kalpadakis; Pavlos Katonis; Kalliopi Alpantaki; Gerassimos A Pangalis; Helen A Papadaki
Journal:  Stem Cells Dev       Date:  2013-02-01       Impact factor: 3.272

10.  Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

Authors:  Paola Secchiero; Sonia Zorzet; Claudio Tripodo; Federica Corallini; Elisabetta Melloni; Lorenzo Caruso; Raffaella Bosco; Sabrina Ingrao; Barbara Zavan; Giorgio Zauli
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.